Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Sanofi signs 2nd biotech deal of the day
Sanofi is paying Adel $80 million in cash, with the total deal potentially reaching up to $1.04 billion, plus royalties.
Gabrielle Masson
Dec 15, 2025 5:50pm
How Zealand CSO aims to create a 'generational biotech leader'
Dec 12, 2025 1:00pm
Cycle Pharma scoops up beleaguered rare disease biotech
Dec 12, 2025 9:55am
Moderna's $500M pact with Nanexa to improve injectables delivery
Dec 11, 2025 7:35am
Zealand pens $2.5B cardiometabolic collab with Chinese biotech
Dec 11, 2025 5:45am
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Dec 10, 2025 11:15am